Craneware PLC
LSE:CRW
Relative Value
The Relative Value of one CRW stock under the Base Case scenario is 2 670.62 GBX. Compared to the current market price of 2 190 GBX, Craneware PLC is Undervalued by 18%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CRW Competitors Multiples
Craneware PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
UK |
Craneware PLC
LSE:CRW
|
778.4m GBP | 5.4 | 103.8 | -2.1 | -5.8 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.6B USD | 13.8 | 61.9 | 61.8 | 66.5 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.7B AUD | 79.8 | 167.3 | 115 | 115 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.1B USD | 11.4 | -337.1 | -175.3 | -162.9 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 32.9 | 22.2 | 23.7 | ||
SE |
Sectra AB
STO:SECT B
|
42.9B SEK | 26.2 | 101 | -66.5 | -66.5 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.2B USD | 1.6 | -22.5 | 26.4 | 281.4 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.3 | 34.2 | -111.8 |